Vera Therapeutics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Vera Therapeutics Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Vera Therapeutics Inc - Ordinary Shares - Class A
Rating: 0.77775
Author: Trendlyne DVM scores

about

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protei...

26.74 -0.05 (-0.19%)

52.29% Fall from 52W High

1.5M

XNAS Volume

XNAS 14 Oct, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

4.5 / 100

Technically Bearish

26.6 / 100

No estimates available

Vera Therapeutics Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Vera Therapeutics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protei...

52.29% Fall from 52W High

SWOT Analysis

Vera Therapeutics Inc (Class A) Live Price Chart

Vera Therapeutics Inc (Class A) Live Price Chart